HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Influence of hypergammaglobulinemia on antiphospholipid antibodies titres].

AbstractPURPOSE:
Antiphospholipid antibodies (aPL), anticardiolipin antibodies (aCL) or lupus anticoagulant (LA), are indispensable for the diagnosis of antiphospholipid syndrome (APS). However, antiphospholipid assays can generate false positive results.
MATERIALS:
We have studied the influence of hypergammaglobulinemia (HG) on aPL antibodies titers in 232 patients twice as positive for aPL antibodies.
RESULTS:
Out of 232 patients, 93 have an APS (76 primary APS, 17 secondary APS). Thrombosis occurred 138 times in APS patients. Of 139 patients without APS, 95 have an auto-immune disease, 28 have an isolated prolonged KCT and 16 an evolutive neoplasia. LA seems to be the best marker of APS. On the other hand aCL IgG and M, anti-beta2-GP1 IgM titers are significantly higher in patients without APS but with HG.
CONCLUSION:
Those results suggest that biological APS diagnosis should be carefully performed in patients with HG. In this case, other additional risk factors must be considered for the etiological diagnosis of thrombosis.
AuthorsM Lambert, A-L Fauchais, S Dubucquoi, D Launay, C Caron, L Prin, E Hachulla, P-Y Hatron, B Devulder
JournalLa Revue de medecine interne (Rev Med Interne) Vol. 25 Issue 2 Pg. 111-4 (Feb 2004) ISSN: 0248-8663 [Print] France
Vernacular TitleEtude de l'influence d'une hypergammaglobulinémie sur le titre des anticorps antiphospholipides.
PMID14744640 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Antibodies, Antiphospholipid
  • Biomarkers
Topics
  • Adult
  • Antibodies, Antiphospholipid (blood)
  • Biomarkers (analysis)
  • False Positive Reactions
  • Female
  • Humans
  • Hypergammaglobulinemia (complications, diagnosis)
  • Male
  • Middle Aged
  • Retrospective Studies
  • Sensitivity and Specificity
  • Thrombosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: